The Valley Desk

NCT02689284 · Interventional trial

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Overall registry status Completed

Phase 1 · Phase 2

Conditions Esophageal Cancer, Gastric Cancer, Stomach Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov